Molecule Details
InChIKeyGKEYKDOLBLYGRB-LGMDPLHJSA-N
Compound NameFamitinib
Canonical SMILESCCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL8.53
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11741
Drug NameFamitinib
CAS Number1044040-56-3
Groups investigational
ATC Codes nan
DescriptionFamitinib has been used in trials studying the treatment of Colorectal Cancer, Renal Cell Cancer, Colorectal Cancer Recurrent, Colorectal Cancer Metastatic, and Metastatic Renal Cell Cancer, among others.

Categories: Heterocyclic Compounds, Fused-Ring Receptor Protein-Tyrosine Kinases, antagonists & inhibitors
Cross-references: BindingDB: 50331023 CHEMBL1278146 ChemSpider: 17595500 PubChem:16662431 PubChem:347828099
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P10721 KIT Homo sapiens Human PF00047 PF07714 8.7 IC50 ChEMBL;BindingDB
P35968 KDR Homo sapiens Human PF07679 PF00047 PF13895 PF22971 PF07714 PF21339 PF17988 PF22854 8.5 IC50 ChEMBL;BindingDB
P09619 PDGFRB Homo sapiens Human PF00047 PF13927 PF25305 PF07714 8.4 IC50 ChEMBL;BindingDB
DrugBank Target Actions (7)
Target Gene Target Name Action Type
P09619 PDGFRB Platelet-derived growth factor receptor beta inhibitor targets
P10721 KIT Mast/stem cell growth factor receptor Kit inhibitor targets
P16234 PDGFRA Platelet-derived growth factor receptor alpha inhibitor targets
P17948 FLT1 Vascular endothelial growth factor receptor 1 inhibitor targets
P35916 FLT4 Vascular endothelial growth factor receptor 3 inhibitor targets
P35968 KDR Vascular endothelial growth factor receptor 2 inhibitor targets
P36888 FLT3 Receptor-type tyrosine-protein kinase FLT3 inhibitor targets